0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Small Molecule CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-31I12456
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecule CDMO Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Small Molecule CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31I12456
Report
November 2024
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Molecule CDMO - Market Size

The global market for Small Molecule CDMO was estimated to be worth US$ 1162 million in 2023 and is forecast to a readjusted size of US$ 2417.3 million by 2030 with a CAGR of 11.5% during the forecast period 2024-2030

Small Molecule CDMO - Market

Small Molecule CDMO - Market

North American market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Small Molecule CDMO by region & country, by Type, and by Application.
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
Market Segmentation

Scope of Small Molecule CDMO - Market Report

Report Metric Details
Report Name Small Molecule CDMO - Market
Forecasted market size in 2030 US$ 2417.3 million
CAGR 11.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Development
  • API Production
Segment by Application
  • Pharmaceutical
  • Biotechnology
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, Jiangsu Sinopep, DELPHARM, Aenova Group, Siegfried Holding AG, Recipharm AB, FAREVA SA, Almac Group, Cambrex, Charles River, CORDEN PHARMA, Jubilant Pharmova, Consort Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Small Molecule CDMO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Small Molecule CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Small Molecule CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Small Molecule CDMO - Market size in 2030?

Ans: The Small Molecule CDMO - Market size in 2030 will be US$ 2417.3 million.

Who are the main players in the Small Molecule CDMO - Market report?

Ans: The main players in the Small Molecule CDMO - Market are Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, Jiangsu Sinopep, DELPHARM, Aenova Group, Siegfried Holding AG, Recipharm AB, FAREVA SA, Almac Group, Cambrex, Charles River, CORDEN PHARMA, Jubilant Pharmova, Consort Medical

What are the Application segmentation covered in the Small Molecule CDMO - Market report?

Ans: The Applications covered in the Small Molecule CDMO - Market report are Pharmaceutical, Biotechnology

What are the Type segmentation covered in the Small Molecule CDMO - Market report?

Ans: The Types covered in the Small Molecule CDMO - Market report are Development, API Production

1 Market Overview
1.1 Small Molecule CDMO Product Introduction
1.2 Global Small Molecule CDMO Market Size Forecast
1.3 Small Molecule CDMO Market Trends & Drivers
1.3.1 Small Molecule CDMO Industry Trends
1.3.2 Small Molecule CDMO Market Drivers & Opportunity
1.3.3 Small Molecule CDMO Market Challenges
1.3.4 Small Molecule CDMO Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Small Molecule CDMO Players Revenue Ranking (2023)
2.2 Global Small Molecule CDMO Revenue by Company (2019-2024)
2.3 Key Companies Small Molecule CDMO Manufacturing Base Distribution and Headquarters
2.4 Key Companies Small Molecule CDMO Product Offered
2.5 Key Companies Time to Begin Mass Production of Small Molecule CDMO
2.6 Small Molecule CDMO Market Competitive Analysis
2.6.1 Small Molecule CDMO Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Small Molecule CDMO Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Development
3.1.2 API Production
3.2 Global Small Molecule CDMO Sales Value by Type
3.2.1 Global Small Molecule CDMO Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Small Molecule CDMO Sales Value, by Type (2019-2030)
3.2.3 Global Small Molecule CDMO Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Biotechnology
4.2 Global Small Molecule CDMO Sales Value by Application
4.2.1 Global Small Molecule CDMO Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Small Molecule CDMO Sales Value, by Application (2019-2030)
4.2.3 Global Small Molecule CDMO Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Small Molecule CDMO Sales Value by Region
5.1.1 Global Small Molecule CDMO Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Small Molecule CDMO Sales Value by Region (2019-2024)
5.1.3 Global Small Molecule CDMO Sales Value by Region (2025-2030)
5.1.4 Global Small Molecule CDMO Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Small Molecule CDMO Sales Value, 2019-2030
5.2.2 North America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Small Molecule CDMO Sales Value, 2019-2030
5.3.2 Europe Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Small Molecule CDMO Sales Value, 2019-2030
5.4.2 Asia Pacific Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Small Molecule CDMO Sales Value, 2019-2030
5.5.2 South America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Small Molecule CDMO Sales Value, 2019-2030
5.6.2 Middle East & Africa Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Small Molecule CDMO Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Small Molecule CDMO Sales Value
6.3 United States
6.3.1 United States Small Molecule CDMO Sales Value, 2019-2030
6.3.2 United States Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Small Molecule CDMO Sales Value, 2019-2030
6.4.2 Europe Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Small Molecule CDMO Sales Value, 2019-2030
6.5.2 China Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.5.3 China Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Small Molecule CDMO Sales Value, 2019-2030
6.6.2 Japan Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Small Molecule CDMO Sales Value, 2019-2030
6.7.2 South Korea Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Small Molecule CDMO Sales Value, 2019-2030
6.8.2 Southeast Asia Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Small Molecule CDMO Sales Value, 2019-2030
6.9.2 India Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.9.3 India Small Molecule CDMO Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Profile
7.1.2 Lonza Main Business
7.1.3 Lonza Small Molecule CDMO Products, Services and Solutions
7.1.4 Lonza Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.1.5 Lonza Recent Developments
7.2 Catalent
7.2.1 Catalent Profile
7.2.2 Catalent Main Business
7.2.3 Catalent Small Molecule CDMO Products, Services and Solutions
7.2.4 Catalent Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.2.5 Catalent Recent Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Profile
7.3.2 Thermo Fisher Main Business
7.3.3 Thermo Fisher Small Molecule CDMO Products, Services and Solutions
7.3.4 Thermo Fisher Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.3.5 Wuxi Apptec Recent Developments
7.4 Wuxi Apptec
7.4.1 Wuxi Apptec Profile
7.4.2 Wuxi Apptec Main Business
7.4.3 Wuxi Apptec Small Molecule CDMO Products, Services and Solutions
7.4.4 Wuxi Apptec Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.4.5 Wuxi Apptec Recent Developments
7.5 PharmaBlock
7.5.1 PharmaBlock Profile
7.5.2 PharmaBlock Main Business
7.5.3 PharmaBlock Small Molecule CDMO Products, Services and Solutions
7.5.4 PharmaBlock Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.5.5 PharmaBlock Recent Developments
7.6 Asym Chemical
7.6.1 Asym Chemical Profile
7.6.2 Asym Chemical Main Business
7.6.3 Asym Chemical Small Molecule CDMO Products, Services and Solutions
7.6.4 Asym Chemical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.6.5 Asym Chemical Recent Developments
7.7 Jiuzhou Pharmaceutical
7.7.1 Jiuzhou Pharmaceutical Profile
7.7.2 Jiuzhou Pharmaceutical Main Business
7.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Products, Services and Solutions
7.7.4 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.7.5 Jiuzhou Pharmaceutical Recent Developments
7.8 Pharmaron Beijing
7.8.1 Pharmaron Beijing Profile
7.8.2 Pharmaron Beijing Main Business
7.8.3 Pharmaron Beijing Small Molecule CDMO Products, Services and Solutions
7.8.4 Pharmaron Beijing Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.8.5 Pharmaron Beijing Recent Developments
7.9 Porton Pharma
7.9.1 Porton Pharma Profile
7.9.2 Porton Pharma Main Business
7.9.3 Porton Pharma Small Molecule CDMO Products, Services and Solutions
7.9.4 Porton Pharma Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.9.5 Porton Pharma Recent Developments
7.10 ChemPartner
7.10.1 ChemPartner Profile
7.10.2 ChemPartner Main Business
7.10.3 ChemPartner Small Molecule CDMO Products, Services and Solutions
7.10.4 ChemPartner Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.10.5 ChemPartner Recent Developments
7.11 Jiangsu Sinopep
7.11.1 Jiangsu Sinopep Profile
7.11.2 Jiangsu Sinopep Main Business
7.11.3 Jiangsu Sinopep Small Molecule CDMO Products, Services and Solutions
7.11.4 Jiangsu Sinopep Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.11.5 Jiangsu Sinopep Recent Developments
7.12 DELPHARM
7.12.1 DELPHARM Profile
7.12.2 DELPHARM Main Business
7.12.3 DELPHARM Small Molecule CDMO Products, Services and Solutions
7.12.4 DELPHARM Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.12.5 DELPHARM Recent Developments
7.13 Aenova Group
7.13.1 Aenova Group Profile
7.13.2 Aenova Group Main Business
7.13.3 Aenova Group Small Molecule CDMO Products, Services and Solutions
7.13.4 Aenova Group Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.13.5 Aenova Group Recent Developments
7.14 Siegfried Holding AG
7.14.1 Siegfried Holding AG Profile
7.14.2 Siegfried Holding AG Main Business
7.14.3 Siegfried Holding AG Small Molecule CDMO Products, Services and Solutions
7.14.4 Siegfried Holding AG Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.14.5 Siegfried Holding AG Recent Developments
7.15 Recipharm AB
7.15.1 Recipharm AB Profile
7.15.2 Recipharm AB Main Business
7.15.3 Recipharm AB Small Molecule CDMO Products, Services and Solutions
7.15.4 Recipharm AB Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.15.5 Recipharm AB Recent Developments
7.16 FAREVA SA
7.16.1 FAREVA SA Profile
7.16.2 FAREVA SA Main Business
7.16.3 FAREVA SA Small Molecule CDMO Products, Services and Solutions
7.16.4 FAREVA SA Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.16.5 FAREVA SA Recent Developments
7.17 Almac Group
7.17.1 Almac Group Profile
7.17.2 Almac Group Main Business
7.17.3 Almac Group Small Molecule CDMO Products, Services and Solutions
7.17.4 Almac Group Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.17.5 Almac Group Recent Developments
7.18 Cambrex
7.18.1 Cambrex Profile
7.18.2 Cambrex Main Business
7.18.3 Cambrex Small Molecule CDMO Products, Services and Solutions
7.18.4 Cambrex Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.18.5 Cambrex Recent Developments
7.19 Charles River
7.19.1 Charles River Profile
7.19.2 Charles River Main Business
7.19.3 Charles River Small Molecule CDMO Products, Services and Solutions
7.19.4 Charles River Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.19.5 Charles River Recent Developments
7.20 CORDEN PHARMA
7.20.1 CORDEN PHARMA Profile
7.20.2 CORDEN PHARMA Main Business
7.20.3 CORDEN PHARMA Small Molecule CDMO Products, Services and Solutions
7.20.4 CORDEN PHARMA Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.20.5 CORDEN PHARMA Recent Developments
7.21 Jubilant Pharmova
7.21.1 Jubilant Pharmova Profile
7.21.2 Jubilant Pharmova Main Business
7.21.3 Jubilant Pharmova Small Molecule CDMO Products, Services and Solutions
7.21.4 Jubilant Pharmova Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.21.5 Jubilant Pharmova Recent Developments
7.22 Consort Medical
7.22.1 Consort Medical Profile
7.22.2 Consort Medical Main Business
7.22.3 Consort Medical Small Molecule CDMO Products, Services and Solutions
7.22.4 Consort Medical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.22.5 Consort Medical Recent Developments
8 Industry Chain Analysis
8.1 Small Molecule CDMO Industrial Chain
8.2 Small Molecule CDMO Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Small Molecule CDMO Sales Model
8.5.2 Sales Channel
8.5.3 Small Molecule CDMO Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Small Molecule CDMO Market Trends
    Table 2. Small Molecule CDMO Market Drivers & Opportunity
    Table 3. Small Molecule CDMO Market Challenges
    Table 4. Small Molecule CDMO Market Restraints
    Table 5. Global Small Molecule CDMO Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Small Molecule CDMO Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Small Molecule CDMO Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Small Molecule CDMO Product Type
    Table 9. Key Companies Time to Begin Mass Production of Small Molecule CDMO
    Table 10. Global Small Molecule CDMO Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Small Molecule CDMO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Small Molecule CDMO Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Small Molecule CDMO Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Small Molecule CDMO Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Small Molecule CDMO Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Small Molecule CDMO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Small Molecule CDMO Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Small Molecule CDMO Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Small Molecule CDMO Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Small Molecule CDMO Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Small Molecule CDMO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Small Molecule CDMO Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Small Molecule CDMO Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Small Molecule CDMO Sales Value by Region (2019-2024) & (%)
    Table 27. Global Small Molecule CDMO Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Small Molecule CDMO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Small Molecule CDMO Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Small Molecule CDMO Sales Value, (2025-2030) & (US$ Million)
    Table 31. Lonza Basic Information List
    Table 32. Lonza Description and Business Overview
    Table 33. Lonza Small Molecule CDMO Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Small Molecule CDMO Business of Lonza (2019-2024)
    Table 35. Lonza Recent Developments
    Table 36. Catalent Basic Information List
    Table 37. Catalent Description and Business Overview
    Table 38. Catalent Small Molecule CDMO Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Small Molecule CDMO Business of Catalent (2019-2024)
    Table 40. Catalent Recent Developments
    Table 41. Thermo Fisher Basic Information List
    Table 42. Thermo Fisher Description and Business Overview
    Table 43. Thermo Fisher Small Molecule CDMO Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Small Molecule CDMO Business of Thermo Fisher (2019-2024)
    Table 45. Thermo Fisher Recent Developments
    Table 46. Wuxi Apptec Basic Information List
    Table 47. Wuxi Apptec Description and Business Overview
    Table 48. Wuxi Apptec Small Molecule CDMO Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Small Molecule CDMO Business of Wuxi Apptec (2019-2024)
    Table 50. Wuxi Apptec Recent Developments
    Table 51. PharmaBlock Basic Information List
    Table 52. PharmaBlock Description and Business Overview
    Table 53. PharmaBlock Small Molecule CDMO Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Small Molecule CDMO Business of PharmaBlock (2019-2024)
    Table 55. PharmaBlock Recent Developments
    Table 56. Asym Chemical Basic Information List
    Table 57. Asym Chemical Description and Business Overview
    Table 58. Asym Chemical Small Molecule CDMO Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Small Molecule CDMO Business of Asym Chemical (2019-2024)
    Table 60. Asym Chemical Recent Developments
    Table 61. Jiuzhou Pharmaceutical Basic Information List
    Table 62. Jiuzhou Pharmaceutical Description and Business Overview
    Table 63. Jiuzhou Pharmaceutical Small Molecule CDMO Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Small Molecule CDMO Business of Jiuzhou Pharmaceutical (2019-2024)
    Table 65. Jiuzhou Pharmaceutical Recent Developments
    Table 66. Pharmaron Beijing Basic Information List
    Table 67. Pharmaron Beijing Description and Business Overview
    Table 68. Pharmaron Beijing Small Molecule CDMO Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Small Molecule CDMO Business of Pharmaron Beijing (2019-2024)
    Table 70. Pharmaron Beijing Recent Developments
    Table 71. Porton Pharma Basic Information List
    Table 72. Porton Pharma Description and Business Overview
    Table 73. Porton Pharma Small Molecule CDMO Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Small Molecule CDMO Business of Porton Pharma (2019-2024)
    Table 75. Porton Pharma Recent Developments
    Table 76. ChemPartner Basic Information List
    Table 77. ChemPartner Description and Business Overview
    Table 78. ChemPartner Small Molecule CDMO Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Small Molecule CDMO Business of ChemPartner (2019-2024)
    Table 80. ChemPartner Recent Developments
    Table 81. Jiangsu Sinopep Basic Information List
    Table 82. Jiangsu Sinopep Description and Business Overview
    Table 83. Jiangsu Sinopep Small Molecule CDMO Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Small Molecule CDMO Business of Jiangsu Sinopep (2019-2024)
    Table 85. Jiangsu Sinopep Recent Developments
    Table 86. DELPHARM Basic Information List
    Table 87. DELPHARM Description and Business Overview
    Table 88. DELPHARM Small Molecule CDMO Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Small Molecule CDMO Business of DELPHARM (2019-2024)
    Table 90. DELPHARM Recent Developments
    Table 91. Aenova Group Basic Information List
    Table 92. Aenova Group Description and Business Overview
    Table 93. Aenova Group Small Molecule CDMO Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Small Molecule CDMO Business of Aenova Group (2019-2024)
    Table 95. Aenova Group Recent Developments
    Table 96. Siegfried Holding AG Basic Information List
    Table 97. Siegfried Holding AG Description and Business Overview
    Table 98. Siegfried Holding AG Small Molecule CDMO Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Small Molecule CDMO Business of Siegfried Holding AG (2019-2024)
    Table 100. Siegfried Holding AG Recent Developments
    Table 101. Recipharm AB Basic Information List
    Table 102. Recipharm AB Description and Business Overview
    Table 103. Recipharm AB Small Molecule CDMO Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Small Molecule CDMO Business of Recipharm AB (2019-2024)
    Table 105. Recipharm AB Recent Developments
    Table 106. FAREVA SA Basic Information List
    Table 107. FAREVA SA Description and Business Overview
    Table 108. FAREVA SA Small Molecule CDMO Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Small Molecule CDMO Business of FAREVA SA (2019-2024)
    Table 110. FAREVA SA Recent Developments
    Table 111. Almac Group Basic Information List
    Table 112. Almac Group Description and Business Overview
    Table 113. Almac Group Small Molecule CDMO Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Small Molecule CDMO Business of Almac Group (2019-2024)
    Table 115. Almac Group Recent Developments
    Table 116. Cambrex Basic Information List
    Table 117. Cambrex Description and Business Overview
    Table 118. Cambrex Small Molecule CDMO Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Small Molecule CDMO Business of Cambrex (2019-2024)
    Table 120. Cambrex Recent Developments
    Table 121. Charles River Basic Information List
    Table 122. Charles River Description and Business Overview
    Table 123. Charles River Small Molecule CDMO Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Small Molecule CDMO Business of Charles River (2019-2024)
    Table 125. Charles River Recent Developments
    Table 126. CORDEN PHARMA Basic Information List
    Table 127. CORDEN PHARMA Description and Business Overview
    Table 128. CORDEN PHARMA Small Molecule CDMO Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Small Molecule CDMO Business of CORDEN PHARMA (2019-2024)
    Table 130. CORDEN PHARMA Recent Developments
    Table 131. Jubilant Pharmova Basic Information List
    Table 132. Jubilant Pharmova Description and Business Overview
    Table 133. Jubilant Pharmova Small Molecule CDMO Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Small Molecule CDMO Business of Jubilant Pharmova (2019-2024)
    Table 135. Jubilant Pharmova Recent Developments
    Table 136. Consort Medical Basic Information List
    Table 137. Consort Medical Description and Business Overview
    Table 138. Consort Medical Small Molecule CDMO Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Small Molecule CDMO Business of Consort Medical (2019-2024)
    Table 140. Consort Medical Recent Developments
    Table 141. Key Raw Materials Lists
    Table 142. Raw Materials Key Suppliers Lists
    Table 143. Small Molecule CDMO Downstream Customers
    Table 144. Small Molecule CDMO Distributors List
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
    Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Small Molecule CDMO Product Picture
    Figure 2. Global Small Molecule CDMO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 4. Small Molecule CDMO Report Years Considered
    Figure 5. Global Small Molecule CDMO Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Molecule CDMO Revenue in 2023
    Figure 7. Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Development Picture
    Figure 9. API Production Picture
    Figure 10. Global Small Molecule CDMO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Small Molecule CDMO Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Pharmaceutical
    Figure 13. Product Picture of Biotechnology
    Figure 14. Global Small Molecule CDMO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Small Molecule CDMO Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Small Molecule CDMO Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Small Molecule CDMO Sales Value (%), (2019-2030)
    Figure 27. United States Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Small Molecule CDMO Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Small Molecule CDMO Sales Value by Application (%), 2023 VS 2030
    Figure 48. Small Molecule CDMO Industrial Chain
    Figure 49. Small Molecule CDMO Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26N13078
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L13782
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26S13718
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16S12875
Fri Mar 21 00:00:00 UTC 2025

Add to Cart